Intravenous amiodarone combined with magnesium sulfate for emergency treatment of malignant ventricular arrhythmia
SU Yue-nan
ZHANG Yi-wei
CHEN Yong-jia
Abstract：Objective To study the effectiveness and safety of intravenous amiodarone combined with mag-nesium sulfate for emergency treatment of malignant ventricular arrhythmia. Methods The 40 cases of sustained ventricular tachycardia with hemodynamic tolerability had intravenous amiodarone. The 22 case for the onset of he-modynamic instability or when ventricular fibrillation episodes, thorough electrical cardioversion, followed by intra-venous amiodarone combined with 25% magnesium sulfate for prevention of attacks. Results Intravenous amioda-rone dosage during the first 24 hours was 750-2850(14 82±387.5)mg, The total arrhythmia control rate was 66.1% (41/62). Heart rate was statistically improved after treatment (P<0.05), while PB, QTc interval and QR S-wave time was not significantly changed (P>0.05). Only one patient suffered from hypotension. Conclusion The emergency treatment of malignant ventricular arrhythmias with intravenous amiodarone combined with magnesiumsulfate shows good efficacy and safety.
Keywords：Malignant ventricular arrhythmiasAmiodaroneMagnesium sulfate
Publication Date：2010-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 307-308 )